Mengqi Xu

Characteristics of Clinical Trials relating to COVID‐19 registered at ClinicalTrials.gov

Jian-Sheng Kang, Yaolong Chen, Q. Zhou, 2020, Journal of clinical pharmacy and therapeutics.

Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles

D. Weinreich, Dateng Li, Shazia Ali, 2023, Scientific reports.

Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events.

M. Ardeleanu, Dateng Li, G. Geba, 2022, The Journal of allergy and clinical immunology.